Adalimumab (anti-TNF-alpha)

Product Name： Biosimilar of Adalimumab

CAS No.:    331731-18-1                             

Formula:    C₆₄₂₈H₉₉₁₂N₁₆₉₄O₁₉₈₇S₄₆                         

Molecular Weight：  148 kDa                  

Type:    Whole antibody                     

Target：TNF alpha
Antibody Form:  Purified immunoglobulin
Physical Form:  Solution
Storage: -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light.

Description
Adalimumab biosimilar is a recombinant human IgG1 monoclonal antibody specific for human tumor necrosis factor (TNF)，was created using phage display technology resulting in an antibody with human derived heavy and light chain variable regions and human IgG1:k constant regions. Adalimumab biosimilar is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) expression system and is purified by a process that includes specific viral inactivation and removal steps. It consists of 1330 amino acids and has a molecular weight of approximately 148 kilodaltons. 

Biological Activity
Adalimumab (anti-TNF-alpha) is the first fully human, recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha.

For research use only.Not for use in humans